THORNROSE VENTURES
Lobbying for ACESO PLASMA, INC · Medical-device company developing non-thermal plasma technology for wound care.
Federal policies, programs, funding, procurement, research, and agency actions related to advanced wound care, non-thermal plasma medical devices, infection control, antimicrobial resistance, trauma care, battlefield medicine, medical-device development, and regulatory pathways.
Federal policies, programs, funding, procurement, research, and agency actions related to advanced wound care, non-thermal plasma medical devices, infection control, antimicrobial resistance, trauma care, battlefield medicine, medical-device development, and regulatory pathways.
Federal policies, programs, funding, procurement, research, and agency actions related to advanced wound care, non-thermal plasma medical devices, infection control, antimicrobial resistance, trauma care, battlefield medicine, medical-device development, and regulatory pathways.
Federal policies, programs, funding, procurement, research, and agency actions related to advanced wound care, non-thermal plasma medical devices, infection control, antimicrobial resistance, trauma care, battlefield medicine, medical-device development, and regulatory pathways.
Federal policies, programs, funding, procurement, research, and agency actions related to advanced wound care, non-thermal plasma medical devices, infection control, antimicrobial resistance, trauma care, battlefield medicine, medical-device development, and regulatory pathways.
Federal policies, programs, funding, procurement, research, and agency actions related to advanced wound care, non-thermal plasma medical devices, infection control, antimicrobial resistance, trauma care, battlefield medicine, medical-device development, and regulatory pathways.
Federal policies, programs, funding, procurement, research, and agency actions related to advanced wound care, non-thermal plasma medical devices, infection control, antimicrobial resistance, trauma care, battlefield medicine, medical-device development, and regulatory pathways.